Sign Up to like & get
recommendations!
0
Published in 2018 at "Trends in Molecular Medicine"
DOI: 10.1016/j.molmed.2018.08.003
Abstract: PIK3CA is one of the most commonly mutated genes in solid cancers. PIK3CA mutations are also found in benign overgrowth syndromes, collectively known as PIK3CA-related overgrowth spectrum (PROS). As in cancer, PIK3CA mutations in PROS…
read more here.
Keywords:
associated pik3ca;
pik3ca mutations;
mutations overgrowth;
cancer ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Pediatric Research"
DOI: 10.1038/pr.2017.155
Abstract: BackgroundFacial infiltrating lipomatosis (FIL) is a congenital disorder that causes overgrowth of one side of the face. The purpose of this study was to determine whether PIK3CA mutations are present in tissues outside of the…
read more here.
Keywords:
infiltrating lipomatosis;
pik3ca mutations;
tissue;
mutations present ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Science"
DOI: 10.1126/science.aaw9032
Abstract: Seeing double can be a good thing Many human breast cancers harbor activating mutations in PIK3CA, the gene coding for the catalytic subunit of phosphoinositide 3-kinase (PI3K). Clinical trials are underway to evaluate the efficacy…
read more here.
Keywords:
breast cancers;
double pik3ca;
pik3ca mutations;
pi3k inhibitors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-22-2115
Abstract: Abstract Purpose: Alpelisib is a PI3K alpha (PI3Kα)-selective inhibitor approved for the treatment of hormone receptor–positive/HER2-negative (HR+/HER2−) PIK3CA-mutated advanced breast cancer (ABC) based on the SOLAR-1 trial, which defined 11 substitutions in exons 7, 9,…
read more here.
Keywords:
biology targetability;
breast;
alp ful;
pik3ca mutations ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-1207
Abstract: Introduction: Clinical research on the predictive value of PIK3CA mutations in hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2–) metastatic breast cancer (mBC) has advanced in recent years. However, knowledge of epidemiological prevalence has…
read more here.
Keywords:
breast;
pik3ca mutations;
prevalence;
pik3ca ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-2217
Abstract: Introduction: This systematic literature review sought to determine the concordance of PIK3CA mutations in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC) patients. Methods: A comprehensive search of PubMed/MEDLINE,…
read more here.
Keywords:
concordance;
pik3ca mutations;
cancer;
receptor ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-ng16
Abstract: PIK3CA is the most frequently mutated oncogene across all human cancers, and codes for p110α, the catalytic subunit of the PI3K complex. PI3K catalyzes the phosphorylation of the lipid PIP2 to PIP3, which initiates a…
read more here.
Keywords:
cancer;
pi3k;
pik3ca mutations;
breast cancer ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-p3-03-01
Abstract: Activating mutations in PIK3CA, the gene coding for the catalytic subunit (p110α) of phosphoinositide-3-kinase (PI3K), are the most frequent oncogenic alterations in estrogen receptor-positive (ER+) breast cancer and are also prevalent in other tumor types.…
read more here.
Keywords:
pik3ca mutations;
breast cancer;
sensitivity;
double pik3ca ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Molecular Cancer Research"
DOI: 10.1158/1557-3125.pi3k-mtor18-a21
Abstract: PIK3CA mutations represent the most frequent oncogenic driver lesion found across all human cancers. Given that single PIK3CA mutations are a predictive biomarker for response to PI3K inhibition, and that these clinical benefits are small,…
read more here.
Keywords:
response;
compound;
pik3ca;
cancer ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2020-019
Abstract: Two glioma driver mutations in PIK3CA promote neuronal hyperactivity via distinct mechanisms.
read more here.
Keywords:
glioma;
induce neuronal;
mutations induce;
neuronal hyperactivity ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Neurosurgery"
DOI: 10.1227/neu.0000000000001875
Abstract: BACKGROUND: Reports suggest that phosphatidylinositol 3-kinase pathway alterations confer increased risk of progression and poor prognosis in oligodendroglioma, IDH-mutant, and 1p/19q-codeleted molecular oligodendrogliomas (mODG). However, factors that affect prognosis in mODG have not been thoroughly…
read more here.
Keywords:
modgs;
pfs;
pik3ca mutations;
radiation ... See more keywords